University of California San Francisco

Joseph Rapp - 144px
Joseph
Rapp
MD

Professor Emeritus of Surgery
Division of Vascular and Endovascular Surgery
Department of Surgery, School of Medicine
University of California, San Francisco

    Education

    Education
    • 1964-68, University of Oregon, B.S., Biology
    • 1969-73, University of Oregon Medical School, M.D., Medicine
    Residencies
    • 1973-74, Baltimore City Hospital, Intern, Medicine
    • 1974-79, Tufts-New England Medical Center, Resident, Surgery
    Postdoctoral Training
    • 2004, Kaiser Permanente - Endovascular Mini Fellowship, Fellow, Surgery, (Vascular)

    Board Certifications

    • American Board of Surgery, 1981
    • American Board of Surgery, Vascular Surgery, 1990

    Clinical Expertise

    Abdominal Aortic Aneurysm
    Carotid Artery Disease
    Chronic Venous Insufficiency
    Complex Limb Revascularization
    Critical Limb Ischemia
    Deep Vein Thrombosis
    Diabetic Vascular Disease
    Dialysis Access
    Endovascular Aneurysm Repair
    Mesenteric Artery Disease
    Peripheral Artery Disease
    Thoracic Aortic Aneurysm
    Thoracic Outlet Syndrome
    Varicose Veins
    Vascular Malformations

    Clinical Trials

    1. Related Conditions: Abdominal Aortic Aneurysm, Aneurysm| Start Date: | End Date:

    Program Affiliations

    Chief, Vascular Surgery Service - San Francisco VA Medical Center

    Grants and Funding

    • LIPOPROTEIN ISOLATION FROM SURGICAL SPECIMENS AND PLASMA | NIH | 1988-07-01 - 1993-06-30 | Role: Principal Investigator
    • LIPOPROTEIN ISOLATION FROM SURGICAL SPECIMENTS AND PLASM | NIH | 1986-12-01 - 1989-11-30 | Role: Principal Investigator

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 125
    1. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
      Staprans I, Pan XM, Rapp JH, Feingold KR| | PubMed
    2. Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography--multicenter comparative phase III study.
      Rapp JH, Wolff SD, Quinn SF, Soto JA, Meranze SG, Muluk S, Blebea J, Johnson SP, Rofsky NM, Duerinckx A, Foster GS, Kent KC, Moneta G, Middlebrook MR, Narra VR, Toombs BD, Pollak J, Yucel EK, Shamsi K, Weisskoff RM| | PubMed
    3. Atheroemboli during renal artery angioplasty: an ex vivo study.
      Hiramoto J, Hansen KJ, Pan XM, Edwards MS, Sawhney R, Rapp JH| | PubMed
    4. Credentialing for carotid artery stenting.
      Schneider DB, Rapp JH| | PubMed
    5. Coronary-artery revascularization before elective major vascular surgery.
      McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, Pierpont G, Santilli S, Rapp J, Hattler B, Shunk K, Jaenicke C, Thottapurathu L, Ellis N, Reda DJ, Henderson WG| | PubMed
    6. Transport of contrast agents in contrast-enhanced magnetic resonance angiography.
      Jou LD, Rapp J, Saloner D| | PubMed
    7. Current status of carotid imaging by MRA.
      Rapp JH, Saloner D| | PubMed
    8. Impact of surgeon and surgical center characteristics on choice of permanent vascular access.
      O'Hare AM, Dudley RA, Hynes DM, McCulloch CE, Navarro D, Colin P, Stroupe K, Rapp J, Johansen KL| | PubMed
    9. Cerebral ischemia and infarction from atheroemboli <100 microm in Size.
      Rapp JH, Pan XM, Yu B, Swanson RA, Higashida RT, Simpson P, Saloner D| | PubMed
    10. Contrast material-enhanced MRA overestimates severity of carotid stenosis, compared with 3D time-of-flight MRA.
      Townsend TC, Saloner D, Pan XM, Rapp JH| | PubMed